Bortezomib-Dexamethasone-Doxorubicin-Study

Clinical trial NCT00401804 · COMPLETED

Trial details

NCT number: NCT00401804
Sponsor: Austrian Forum Against Cancer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma Renal Insuficiency

Start date: 2006-02-01
Primary completion: 2008-11-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.